This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Otsuka Pharmaceutical Factory, Inc., Toyo Sugar Refining Co., Ltd.. Active years: 2024.
Company Filing History:
1 out of 192 
1 out of 1 Years Active: 2024
Title: Kyo Aizawa: Innovator in Keratoconjunctival Health
Introduction
Kyo Aizawa is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of ophthalmology, particularly in the development of protective agents for the keratoconjunctiva. His innovative work has the potential to improve the quality of life for individuals suffering from keratoconjunctival disorders.
Latest Patents
Aizawa holds a patent for a protective agent for the keratoconjunctiva or a suppressive agent for keratoconjunctival disorders. The patent, which is focused on the use of glucosylglycerol as an active ingredient, aims to provide an excellent suppressive effect on keratoconjunctival disorders. This invention not only highlights Aizawa's ingenuity but also addresses a critical need in the medical community.
Career Highlights
Throughout his career, Kyo Aizawa has worked with prominent companies such as Toyo Sugar Refining Co., Ltd. and Otsuka Pharmaceutical Factory, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
Aizawa has collaborated with notable colleagues, including Yoshihisa Iida and Takashi Shimoida. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Kyo Aizawa's contributions to keratoconjunctival health through his patent and career achievements underscore his role as an influential inventor. His work continues to pave the way for advancements in ophthalmic treatments.